# US 2018/0023115 A1 · Nanopore Detection of Target Polynucleotides From Sample Background

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023115 A1
- Document ID: US20180023115A1
- Status: Published application
- Kind: A1
- Application number: 15/547,434
- Filed: 2016-02-02
- Published: 2018-01-25
- Earliest claimed: 2015-02-02
- Assignees: Two Pore Guys, Inc.
- Applicants: Two Pore Guys, Inc.
- Inventors: Trevor J. Morin; Tyler Shropshire; William B. Dunbar; Daniel A. Heller; Hongyun Wang
- Web page: https://patentgrep.com/patent/US20180023115A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q 1/6851: Quantitative amplification
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Disclosed herein are methods and compositions for detection of target polynucleotides in a mixed sample by amplification of the target polynucleotide and detection in a nanopore device.

## Claims

### Claim 1

A method for detecting the presence or absence of a target polynucleotide sequence suspected to be present in a sample, comprising:
providing a set of primers, wherein at least one of said primers is hybridizable to a polynucleotide comprising said target polynucleotide sequence, and wherein at least one of said primers is modified to comprise a conjugation site capable of specifically binding to a payload molecule;
performing an amplification reaction on said sample, wherein said sample comprises said primer set and reagents for amplification, such that an amplicon comprising said target polynucleotide sequence generated by said amplification reaction will comprise said conjugation site;
binding said payload molecule to said conjugation site;
loading said sample into a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the nucleic acid through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore; and
detecting the presence or absence of said target polynucleotide sequence in said sample by determining whether the target polynucleotide bound to the payload molecule passed through the nanopore using data from said sensor.

### Claim 2 (depends on 1)

The method of claim 1, wherein said sample is loaded into said device before said amplification.

### Claim 3 (depends on 1)

The method of claim 1, wherein said sample is loaded into said device after said amplification.

### Claim 4 (depends on 1)

The method of claim 1, wherein said payload molecule is bound to said conjugation site of said amplicon after said amplification.

### Claim 5 (depends on 1)

The method of claim 1, wherein said payload molecule is bound to said conjugation site of said primer before said amplification.

### Claim 6 (depends on 1)

The method of claim 1, wherein said sample does not undergo a purification step between said amplification and said detection in a nanopore.

### Claim 7 (depends on 1)

The method of claim 1, wherein said sample is loaded into said nanopore device at a dilution of at least 1:20000, 1:10000, 1:5000, 1:2000, 1:1000, 1:500, 1:200, 1:100, 1:50, 1:20, 1:10, 1:5, 1:2, 1:1.5, 1:1.2, 1:1.1 or 1:1.05.

### Claim 8 (depends on 1)

The method of claim 1, wherein said sample is loaded into said nanopore device without dilution.

### Claim 9 (depends on 1)

The method of claim 1, wherein said sample comprises non-target polynucleotides and amplification reaction reagents.

### Claim 10 (depends on 1)

The method of claim 1, wherein said nanopore is at least 5 nm, 10 nm, 20 nm, 30 nm, 40 nm, or 50 nm in diameter.

### Claim 11 (depends on 1)

The method of claim 1, wherein said amplification reaction is selected from the group consisting of: polymerase chain reaction (PCR), reverse transcription PCR, ligation mediated PCR, loop mediated amplification (LAMP), isothermal amplification, strand displacement amplification (SDA), multiple displacement amplification, strand displacement amplification, helicase dependent amplification, nicking enzyme amplification reaction, or recombinant polymerase amplification.

### Claim 12 (depends on 1)

The method of claim 1, wherein said amplification reaction is performed in the interior space of the device.

### Claim 13 (depends on 1)

The method of claim 1, wherein the target polynucleotide comprises double-stranded deoxyribonucleic acid (dsDNA), single-stranded DNA (ssDNA), peptide nucleic acid (PNA), single-stranded ribonucleic acid (ssRNA), DNA/RNA hybrid, or double-stranded ribonucleic acid (dsRNA).

### Claim 14 (depends on 1)

The method of claim 1, wherein the target polynucleotide is a naturally-occurring polynucleotide.

### Claim 15 (depends on 1)

The method of claim 1, wherein the target polynucleotide is an artificially synthesized polynucleotide.

### Claim 16 (depends on 1)

The method of claim 1, wherein the target polynucleotide is a recombinant polynucleotide.

### Claim 17 (depends on 1)

The method of claim 1, wherein the payload molecule is selected from the group consisting of: a dendrimer, double stranded DNA, single stranded DNA, a DNA aptamer, a fluorophore, a protein, an antibody, a polypeptide, a nanobead, a nanorod, a nanotube, nanoparticle, fullerene, a PEG molecule, a liposome, or a cholesterol-DNA hybrid.

### Claim 18 (depends on 1)

The method of claim 1, wherein said payload molecule comprises an electrical charge.

### Claim 19 (depends on 18)

The method of claim 18, wherein said charged payload molecule is selected form the group consisting of: a peptide, an amino acid, a charged nanoparticle, a synthetic molecule, a nucleotide, a polynucleotide, a metal, or an ion.

### Claim 20 (depends on 18)

The method of claim 18, wherein the sensitivity or specificity of detection of the presence of absence of the target polynucleotide is increased when said target polynucleotide is bound to said charged payload molecule as compared to unbound target polynucleotide.

### Claim 21 (depends on 1)

The method of claim 1, wherein the sensitivity or specificity of detection of the presence or absence of the target polynucleotide is increased when said target polynucleotide is bound to said payload molecule as compared to unbound target polynucleotide.

### Claim 22 (depends on 1)

The method of claim 1, wherein the sensor comprises an electrode pair configured to apply a voltage differential between the two volumes and to measure current flow through the nanopore separating the two volumes, generating a current event signature.

### Claim 23 (depends on 22)

The method of claim 22, wherein the current event signature generated when the payload-bound target polynucleotide passes through the nanopore is distinguishable from the current event signature of background molecules by its mean depth, maximum depth, duration, number of depth levels, area of depth and duration, or noise level.

### Claim 24 (depends on 1)

The method of claim 1, wherein the conjugation site and the payload molecule are bound via a covalent bond.

### Claim 25 (depends on 24)

The method of claim 24, wherein said covalent bond is formed by click chemistry.

### Claim 26 (depends on 25)

The method of claim 25, wherein said click chemistry is copper catalyzed.

### Claim 27 (depends on 25)

The method of claim 25, wherein said click chemistry is copper free.

### Claim 28 (depends on 1)

The method of claim 1, wherein the conjugation site and the payload molecule are bound via a non-covalent bond.

### Claim 29 (depends on 28)

The method of claim 28, wherein said non-covalent bond is a hydrogen bond, an ionic bond, a van der Waals interaction, a hydrophobic interaction, a polar bond, a cation-pi interaction, a planar stacking interaction, or a metallic bond.

### Claim 30 (depends on 1)

The method of claim 1, wherein the conjugation site is located at the 3′ or the 5′ end of the said primer.

### Claim 31 (depends on 1)

The method of claim 1, wherein the conjugation site is located at the 3′ or the 5′ end of the said amplicon.

### Claim 32 (depends on 1)

The method of claim 1, wherein the conjugation site comprises a chemical group, a reactive group, a small molecule, or a peptide.

### Claim 33 (depends on 32)

The method of claim 32, wherein the small molecule comprises biotin.

### Claim 34 (depends on 32)

The method of claim 32, wherein the reactive group comprises dibenzocyclooctyl (DBCO) or azide.

### Claim 35 (depends on 1)

The method of claim 1, wherein two or more payload molecules are bound to said amplicon.

### Claim 36 (depends on 1)

The method of claim 1, wherein said device comprises at least two nanopores in series, and wherein said amplicon bound to said payload molecule is simultaneously in said at least two nanopores during translocation.

### Claim 37

A method for detecting the presence or absence of a target polynucleotide sequence suspected to be present in a sample, comprising:
providing a set of primers, wherein at least one of said primers is hybridizable to a polynucleotide comprising said target polynucleotide sequence, and wherein at least one of said primers is bound to a payload molecule;
performing an amplification reaction on said sample, wherein said sample comprises said primer set and reagents for amplification, such that an amplicon comprising said target polynucleotide sequence generated by said amplification reaction will be bound to said payload molecule;
loading said sample into a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the nucleic acid through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore; and
detecting the presence or absence of said target polynucleotide sequence in said sample by determining whether the target polynucleotide bound to the payload molecule passed through the nanopore using data from said sensor.

### Claim 38 (depends on 37)

The method of claim 37, wherein said sample is loaded into said device before said amplification.

### Claim 39 (depends on 37)

The method of claim 37, wherein said sample is loaded into said device after said amplification.

### Claim 40 (depends on 37)

The method of claim 37, wherein said sample does not undergo a purification step between said amplification and said detection in a nanopore.

### Claim 41 (depends on 37)

The method of claim 37, wherein said sample is loaded into said nanopore device at a dilution of 1:10000, 1:1000, 1:500, 1:200, 1:100, 1:50, 1:20, 1:10, 1:5, 1:2, 1:1.5, 1:1.2, 1:1.1 or 1:1.05.

### Claim 42 (depends on 37)

The method of claim 37, wherein said sample is loaded into said nanopore device without dilution.

### Claim 43 (depends on 37)

The method of claim 37, wherein said sample comprises non-target polynucleotides and amplification reaction reagents.

### Claim 44 (depends on 37)

The method of claim 37, wherein said nanopore is at least 5 nm, 10 nm, 20 nm, 30 nm, 40 nm, or 50 nm in diameter.

### Claim 45 (depends on 37)

The method of claim 37, wherein said amplification reaction is selected from the group consisting of: polymerase chain reaction (PCR), reverse transcription PCR, ligation mediated PCR, loop mediated amplification (LAMP), isothermal amplification, strand displacement amplification (SDA), multiple displacement amplification, strand displacement amplification, helicase dependent amplification, nicking enzyme amplification reaction, or recombinant polymerase amplification.

### Claim 46 (depends on 37)

The method of claim 37, wherein said amplification reaction is performed in the interior space of the device.

### Claim 47 (depends on 37)

The method of claim 37, wherein the target polynucleotide comprises double-stranded deoxyribonucleic acid (dsDNA), single-stranded DNA (ssDNA), peptide nucleic acid (PNA), single-stranded ribonucleic acid (ssRNA), DNA/RNA hybrid, or double-stranded ribonucleic acid (dsRNA).

### Claim 48 (depends on 37)

The method of claim 37, wherein the target polynucleotide is a naturally-occurring polynucleotide.

### Claim 49 (depends on 37)

The method of claim 37, wherein the target polynucleotide is an artificially synthesized polynucleotide.

### Claim 50 (depends on 37)

The method of claim 37, wherein the target polynucleotide is a recombinant polynucleotide.

### Claim 51 (depends on 37)

The method of claim 37, wherein the payload molecule is selected from the group consisting of: a dendrimer, double stranded DNA, single stranded DNA, a DNA aptamer, a fluorophore, a protein, an antibody, a polypeptide, a nanobead, a nanorod, a nanotube, nanoparticle, fullerene, a PEG molecule, a liposome, or a cholesterol-DNA hybrid.

### Claim 52 (depends on 37)

The method of claim 37, wherein said payload molecule comprises an ionic charge.

### Claim 53 (depends on 52)

The method of claim 52, wherein said charged payload molecule is selected form the group consisting of: a peptide, an amino acid, a charged nanoparticle, a synthetic molecule, a nucleotide, a polynucleotide, a metal, or an ion.

### Claim 54 (depends on 52)

The method of claim 52, wherein the sensitivity or specificity of detection of the presence or absence of the target polynucleotide is increased when said target polynucleotide is bound to said charged payload molecule as compared to unbound target polynucleotide.

### Claim 55 (depends on 37)

The method of claim 37, wherein the sensitivity or specificity of detection of the presence of absence of the target polynucleotide is increased when said target polynucleotide is bound to said payload molecule as compared to unbound target polynucleotide.

### Claim 56 (depends on 37)

The method of claim 37 wherein the sensor comprises an electrode pair configured to apply a voltage differential between the two volumes and to measure current flow through the nanopore separating the two volumes, generating a current event signature.

### Claim 57 (depends on 56)

The method of claim 56, wherein the current event signature generated when the payload-bound target polynucleotide passes through the nanopore is distinguishable from the current event signature of background molecules by its mean depth, maximum depth, duration, number of depth levels, area of depth and duration, or noise level.

### Claim 58 (depends on 37)

The method of claim 37, wherein the primer and the payload molecule are bound via a covalent bond.

### Claim 59 (depends on 37)

The method of claim 37, wherein the primer and the payload molecule are bound via a non-covalent bond.

### Claim 60 (depends on 37)

The method of claim 37, wherein the payload molecule is bound at the 3′ or the 5′ end of the said primer.

### Claim 61 (depends on 37)

The method of claim 37, wherein two or more payload molecules are bound to said primer.

### Claim 62 (depends on 37)

The method of claim 37, wherein the amplicon and the payload molecule are bound via a covalent bond.

### Claim 63 (depends on 37)

The method of claim 37, wherein the amplicon and the payload molecule are bound via a non-covalent bond.

### Claim 64 (depends on 37)

The method of claim 37, wherein two or more payload molecules are bound to said amplicon.

### Claim 65 (depends on 37)

The method of claim 37, wherein said device comprises at least two nanopores in series, and wherein said amplicon bound to said payload molecule is simultaneously in said at least two nanopores during translocation.

### Claim 66

A method for detecting the presence or absence of a target polynucleotide sequence suspected to be present in a sample, comprising:
providing a set of primers, wherein at least one of said primers is hybridizable to a polynucleotide comprising said target polynucleotide sequence;
performing an amplification reaction on said sample, wherein said sample comprises said primer set and reagents for amplification, such that an amplicon comprising said target polynucleotide sequence generated by said amplification reaction is at least 100 base pairs in length;
loading said sample into a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the nucleic acid through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore; and
detecting the presence or absence of said target polynucleotide sequence in said amplified sample by determining whether the target polynucleotide bound to the payload molecule passed through the nanopore using data from said sensor, wherein said amplified sample has not been purified.

### Claim 67 (depends on 66)

The method of claim 66, wherein said sample is loaded into said device before said amplification.

### Claim 68 (depends on 66)

The method of claim 66, wherein said sample is loaded into said device after said amplification.

### Claim 69 (depends on 66)

The method of claim 66, wherein said amplicon is at least 200, 500, 1,000, 2,000, 5,000 or 10,000 base pairs in length.

### Claim 70 (depends on 66)

The method of claim 66, wherein said sample does not undergo a purification step between said amplification and said detection in a nanopore.

### Claim 71 (depends on 66)

The method of claim 66, wherein said sample is loaded into said nanopore device at a dilution of 1:10000, 1:1000, 1:500, 1:200, 1:100, 1:50, 1:20, 1:10, 1:5, 1:2, 1:1.5, 1:1.2, 1:1.1 or 1:1.05.

### Claim 72 (depends on 66)

The method of claim 66, wherein said sample is loaded into said nanopore device without dilution.

### Claim 73 (depends on 66)

The method of claim 66, wherein said sample comprises non-target polynucleotides and amplification reaction reagents.

### Claim 74 (depends on 66)

The method of claim 66, wherein said nanopore is at least 2 nm, 3 nm, 5 nm, 10 nm, 20 nm, 30 nm, 40 nm, or 50 nm in diameter.

### Claim 75 (depends on 66)

The method of claim 66, wherein said amplification reaction is selected from the group consisting of: polymerase chain reaction (PCR), reverse transcription PCR, ligation mediated PCR, loop mediated amplification (LAMP), isothermal amplification, strand displacement amplification (SDA), multiple displacement amplification, strand displacement amplification, helicase dependent amplification, nicking enzyme amplification reaction, recombinant polymerase amplification, loop mediated isothermal amplification (LAMP<self-sustained sequence replication, whole genome amplification, or ligase mediated PCR.

### Claim 76 (depends on 66)

The method of claim 66, wherein said amplification reaction is performed in the interior space of the device.

### Claim 77 (depends on 66)

The method of claim 66, wherein the target polynucleotide comprises double-stranded deoxyribonucleic acid (dsDNA), single-stranded DNA (ssDNA), DNA/RNA hybrid, peptide nucleic acid (PNA), single-stranded ribonucleic acid (ssRNA), or double-stranded ribonucleic acid (dsRNA).

### Claim 78 (depends on 66)

The method of claim 66, wherein the target polynucleotide is a naturally-occurring polynucleotide.

### Claim 79 (depends on 66)

The method of claim 66, wherein the target polynucleotide is an artificially synthesized polynucleotide.

### Claim 80 (depends on 66)

The method of claim 66, wherein the target polynucleotide is a recombinant polynucleotide.

### Claim 81 (depends on 66)

The method of claim 66, wherein the sensor comprises an electrode pair configured to apply a voltage differential between the two volumes and to measure current flow through the nanopore separating the two volumes, generating a current event signature.

### Claim 82 (depends on 81)

The method of claim 81, wherein the current event signature generated when the target polynucleotide passes through the nanopore is distinguishable from the current event signature of background molecules by its mean depth, maximum depth, duration, number of depth levels, area of depth and duration, or noise level.

### Claim 83 (depends on 66)

The method of claim 66, wherein said device comprises at least two nanopores in series, and wherein said amplicon is simultaneously in said at least two nanopores during translocation.

### Claim 84

A kit comprising:
a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the nucleic acid through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore;
a primer set, wherein at least one of said primers is hybridizable to a polynucleotide comprising said target polynucleotide sequence, and wherein at least one of said primers is modified to comprise a conjugation site capable of specifically binding to a payload molecule;
a payload molecule for binding to said conjugation site prior to, during, or after amplification;
instructions for use to detect the presence or absence of said target polynucleotide in a sample.

### Claim 85

A kit comprising:
a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the nucleic acid through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore;
a primer set, wherein at least one of said primers is hybridizable to a polynucleotide comprising said target polynucleotide sequence, and wherein at least one of said primers is bound to a payload molecule;
instructions for use to detect the presence or absence of said target polynucleotide in a sample.

### Claim 86

A kit comprising:
a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the nucleic acid through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore;
a primer set, wherein at least one of said primers is hybridizable to a polynucleotide comprising said target polynucleotide sequence, wherein said primers generate an amplicon comprising said target polynucleotide sequence of at least 100, 200, 500, 1,000, 2,000, 5,000, or 10,000 base pairs during an amplification reaction; and
instructions for use to detect the presence or absence of said target polynucleotide in a sample.

### Claim 87

A method for quantifying the amount of target polynucleotide sequence present in a sample, comprising:
providing a control sample comprising a known amount of a control polynucleotide and an experimental sample comprising an unknown amount of target polynucleotide;
amplifying said control sample to generate a first amplicon comprising said control polynucleotide and amplifying said experimental sample to generate a second amplicon comprising said target polynucleotide;
loading said control sample and said experimental sample separately into a device comprising a nanopore, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the first or second amplicon through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore; and
comparing the capture rate of said first amplicon in the nanopore with the capture rate of said second amplicon in the nanopore to quantify the amount of target polynucleotide sequence in said experimental sample.

### Claim 88 (depends on 87)

The method of claim 87, wherein said amplification is performed after loading said control sample or said experimental sample into said device.

### Claim 89 (depends on 87)

The method of claim 87, wherein said control sample and said experimental sample are amplified under identical conditions.

### Claim 90 (depends on 87)

The method of claim 87, wherein said control polynucleotide and said target polynucleotide are of the same length or sequence.

### Claim 91 (depends on 87)

The method of claim 87, wherein the capture rate of the first and second amplicon are determined using the same nanopore under the same conditions.

### Claim 92 (depends on 87)

The method of claim 87, wherein the capture rate of the first and second amplicon are determined using nanopores of similar size.

### Claim 93 (depends on 87)

The method of claim 87, wherein an estimate for the concentration of the target polynucleotide in the experimental sample is mathematically generated by aggregating the set of sensor measurements recorded over time for said control sample and said experimental sample and comparing the two sets of data to convert capture rate to concentration.

### Claim 94 (depends on 87)

The method of claim 87, wherein after each cycle within an amplification reaction, an estimate for the concentration of the target polynucleotide is mathematically generated by aggregating the set of sensor measurements recorded over time for said control sample and said experimental sample and comparing the two sets of data to convert capture rate to concentration.

### Claim 95 (depends on 94)

The method of claim 94, further comprising determining the amount of target polynucleotide in said experimental sample before amplification from said comparison of sensor measurements.

### Claim 96

A method for quantifying the amount of target polynucleotide sequence present in a sample, comprising:
providing a control sample comprising a known amount of a control polynucleotide and an experimental sample comprising an unknown amount of target polynucleotide;
diluting said control sample to generate at least two different known concentrations of said control polynucleotide;
loading said control sample into a device comprising a nanopore at said at least two different known concentrations of said control polynucleotide, wherein said nanopore separates an interior space of the device into two volumes, and configuring the device to pass the control polynucleotide through one or more pores, wherein the device comprises a sensor for each pore that is configured to identify objects passing through the nanopore;
detecting the capture rate in said nanopore of the control polynucleotide at each of said at least two known concentrations;
amplifying said experimental sample to generate an amplicon comprising said target polynucleotide; and
loading the experimental sample into said device comprising a nanopore;
detecting the capture rate of the target polynucleotide in said nanopore;
comparing the capture rate of said first amplicon in the nanopore with the capture rate of said second amplicon in the nanopore to quantify the amount of target polynucleotide sequence in said experimental sample.

### Claim 97 (depends on 96)

The method of claim 96, wherein said dilution is a serial dilution.

### Claim 98 (depends on 96)

The method of claim 96, further comprising amplifying said control polynucleotide.

### Claim 99 (depends on 96)

The method of claim 96, wherein said dilution is performed after loading said control sample into said device.

### Claim 100 (depends on 96)

The method of claim 96, wherein said amplification is performed after loading said experimental sample in to said device.
